Abstract
Chronic obstructive pulmonary disease (COPD) is a common chronic pulmonary inflammatory disease, which is characterized by progressively increased irreversible airflow limitation.In clinical practice, based on the presence of chronic airflow limitation, lung function tests are often used to diagnose and assess the severity of COPD and clinical efficacy.However, in primary hospitals, pulmonary function has not yet been popularized, and some patients with severe disease are unable to perform pulmonary function tests.Clinically, simple and reliable inflammatory markers are needed to assess the severity of illness, risk of acute exacerbations, clinical efficacy, and prognosis of COPD patients.This article reviews recent advances in COPD-related inflammatory markers. Key words: Inflammatory markers; Chronic obstructive pulmonary disease; Recent advances
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
